Insider Buying: GSK plc (LON:GSK) Insider Buys 8 Shares of Stock

GSK plc (LON:GSKGet Free Report) insider Julie Brown purchased 8 shares of the stock in a transaction dated Tuesday, June 11th. The stock was bought at an average cost of GBX 1,623 ($20.67) per share, with a total value of £129.84 ($165.34).

GSK Stock Down 0.3 %

Shares of GSK stock opened at GBX 1,604.50 ($20.43) on Friday. The firm has a market cap of £65.46 billion, a PE ratio of 1,472.02, a P/E/G ratio of 1.19 and a beta of 0.27. The business’s 50 day simple moving average is GBX 1,690.77 and its 200 day simple moving average is GBX 1,618.77. The company has a debt-to-equity ratio of 134.34, a quick ratio of 0.73 and a current ratio of 0.87. GSK plc has a 52-week low of GBX 1,302.60 ($16.59) and a 52-week high of GBX 1,823.50 ($23.22).

GSK Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be given a GBX 15 ($0.19) dividend. This represents a dividend yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio is presently 5,504.59%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on GSK shares. Shore Capital reissued a “buy” rating on shares of GSK in a report on Wednesday. Barclays reissued an “equal weight” rating and issued a GBX 1,725 ($21.97) target price on shares of GSK in a research note on Tuesday, May 7th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,950 ($24.83) price target on shares of GSK in a research report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of GBX 1,675.63 ($21.34).

View Our Latest Research Report on GSK

About GSK

(Get Free Report)

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.

Read More

Insider Buying and Selling by Quarter for GSK (LON:GSK)

Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with MarketBeat.com's FREE daily email newsletter.